75 results
8-K
EX-99.1
AFIB
Acutus Medical Inc
1 Apr 24
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
4:13pm
expenses.
Operating expenses for continuing operations, consisting of research and development, and selling, general and administrative expenses … expenses resulted from reduced discretionary spend, and the reprioritization of certain research and development programs.
Net loss on continuing
8-K
EX-10.1
AFIB
Acutus Medical Inc
11 Jan 24
Departure of Directors or Certain Officers
4:03pm
and all combinations of individual items of information) that relates to the actual or anticipated business and/or products, research or development
8-K
EX-10.1
cxxrugsrb82
9 Nov 23
Entry into a Material Definitive Agreement
6:41pm
8-K
EX-99.1
4vufkbgyr p72j1y54r
8 Nov 23
Acutus Medical Reports Third Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
r787hse w9
7 Aug 23
Acutus Medical Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
flhdlaf
11 May 23
Acutus Medical Reports First Quarter 2023 Financial Results
4:03pm
424B5
ze6es63d sgag4q
21 Dec 22
Prospectus supplement for primary offering
4:35pm
8-K
EX-99.1
a4jdgr
10 Nov 22
Acutus Medical Reports Third Quarter 2022 Financial Results
4:04pm
8-K/A
EX-99.2
4s8gdnx4lmguk0y1j1i
11 Aug 22
Other Events
5:08pm
8-K
EX-99.1
z2b6ok91r1h9
11 Aug 22
Acutus Medical Reports Second Quarter 2022 Financial Results
4:09pm